台股 » 個股 » 智基 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

智基

(6294)
可現股當沖
  • 股價
    60.0
  • 漲跌
    ▲0.2
  • 漲幅
    +0.33%
  • 成交量
    11
  • 產業
    上櫃 文化創意指數
  • 105人加入追蹤

    立即追蹤

  • 本地時間:14:30

     
智基 (6294)籌碼相關-臺銀-高雄 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

臺銀-高雄 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/1600.00159.0059.00-191-1.09%
2025/01/13159.0000.0059.401911.09%
2025/01/1000.00160.0059.60-191-1.10%
2025/01/09160.2000.0060.101911.10%
2024/12/31760.50160.5061.106906.61%
2024/12/30061.0000.0060.800900.00%
2024/12/2700.00261.5062.10-290-2.21%
2024/12/2600.001961.4061.10-1990-21.03%
2024/12/2500.0010.561.5061.50-10.590-11.66%
2024/12/198.160.5000.0061.008.1908.86%
2024/12/171760.5000.0060.70179118.64%
2024/12/160.162.0000.0062.100.1900.11%
2024/12/130.163.0000.0063.100.1890.06%
2024/12/120.463.1500.0063.800.4890.47%
2024/12/11064.5000.0064.000900.00%
2024/12/020.165.1000.0064.900.1970.07%
2024/11/260.266.0000.0065.300.2990.20%
2024/11/21062.2000.0063.300940.00%
2024/11/200.265.3100.0064.400.2910.24%
2024/11/192.169.3000.0069.302.1882.34%
2024/11/180.170.9600.0070.700.1900.06%
2024/11/159.169.72171.1072.608.11017.90%
2024/11/140.672.10271.6569.70-1.4102-1.36%
2024/11/1323.177.541.177.9677.40229722.46%
2024/11/120.286.5400.0086.000.2900.20%
2024/11/06097.5000.0096.9001240.00%
2024/11/04596.40197.9097.5041323.01%
2024/11/01596.4000.0096.5051343.71%
2024/10/25196.5000.0096.5011360.74%
2024/10/2310.196.55096.9096.5010.11367.36%
2024/10/2100.00098.0096.700137-0.01%
2024/10/160.197.0000.0096.900.11370.04%
2024/10/111597.0000.0097.401513710.87%
2024/10/08597.0000.0097.0051383.61%
2024/10/0700.00197.1096.80-1138-0.72%
2024/09/18096.9000.0096.2001390.01%
2024/09/1600.00097.8096.8001390.00%
2024/09/13196.9000.0096.8011400.71%
2024/09/12097.2000.0096.8001400.01%
2024/09/11096.4000.0096.1001390.02%
2024/09/10097.6000.0096.5001390.03%
2024/09/090.198.5000.0098.100.11370.04%
2024/08/3000.000101.50101.0001390.00%
2024/08/2900.000100.50101.000138-0.01%
2024/08/2600.000102.13101.000137-0.03%
2024/08/231102.001102.00102.0001360.00%
2024/08/221102.501.1102.06102.00-0.1136-0.11%
2024/08/211104.504103.37102.00-3135-2.20%
2024/08/204106.504105.13104.5001330.00%
2024/08/193106.000.2106.50106.002.81302.15%
2024/08/1600.002105.25105.00-2118-1.68%
2024/08/151103.5100.00102.5011140.90%
2024/08/142102.7500.00104.5021121.77%
2024/08/131105.001101.50101.5001090.00%
2024/08/120101.7900.00102.500990.01%
2024/08/09199.911.2100.83100.50-0.293-0.20%
2024/08/080103.5000.00105.000950.00%
2024/08/0700.001109.00108.00-197-1.02%
2024/08/050.298.9000.0098.800.2890.22%
2024/07/2300.000.2101.50101.50-0.290-0.22%
2024/07/190101.500101.00101.50089-0.03%
2024/07/1800.001101.50101.50-190-1.15%
2024/07/160102.0000.00102.000910.00%
2024/07/120101.5000.00102.000930.01%
2024/06/2600.001100.50100.50-1137-0.73%
2024/06/2100.000.1100.50100.50-0.1140-0.07%
2024/06/170.1101.0000.00101.000.11460.07%
2024/06/0600.001102.50102.50-1157-0.63%
2024/05/171.1106.9300.00105.501.11520.69%
2024/05/1500.000.3103.00104.00-0.3148-0.20%
2024/05/141101.981102.00102.0001440.02%
2024/05/130.1107.000.4107.00107.00-0.3127-0.25%
2024/05/0300.002118.50118.50-2117-1.70%
2024/05/0200.002118.00118.00-2116-1.71%
2024/04/2900.000.2118.00117.50-0.2116-0.17%
2024/04/171116.5000.00117.0011110.89%
2024/04/1200.002118.00118.00-2104-1.91%
2024/04/1100.000119.00119.5001010.00%
2024/04/1000.000.5125.90127.00-0.595-0.52%
2024/04/090124.200.1124.00124.00-0.177-0.12%
2024/03/2500.000.3123.68124.00-0.362-0.48%
2024/03/2200.000.4123.50122.50-0.460-0.66%
2024/03/211122.000.1122.75121.500.9581.54%
2024/03/2000.000.6123.17121.50-0.656-1.06%
2024/03/1900.000.1123.00123.00-0.155-0.18%
2024/03/1800.001123.00124.00-151-1.95%
2024/03/1400.002119.00119.00-243-4.62%
2024/03/130.2116.963117.00116.50-2.839-7.09%
2024/03/121117.0000.00117.001382.57%
2024/03/1100.000.1114.50114.50-0.136-0.39%
2024/03/0700.001114.50114.00-134-2.91%
2024/03/0600.003114.00113.50-334-8.73%
2024/03/041113.0000.00112.501333.03%
2024/03/0100.002112.50112.50-232-6.14%
2024/02/291112.000.2112.50112.500.9322.63%
2024/02/270.2112.5000.00112.500.2320.46%
2024/02/1900.001113.00113.00-131-3.18%
2024/02/0200.001112.50112.00-131-3.16%
慧智基因前列腺癌基因檢測套組 推行至國內千名患者Anue鉅亨-2021/09/14
疫情推升醫材需求強 雃博5月營收創同期高 慧智基因寫新猷Anue鉅亨-2021/06/10
智基 相關文章
智基 相關影音